Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5541)
All Articles published online
|
Aug 21, 2012 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | La Greca G, Sofia M, Lombardo R, Latteri S, Ricotta A, Puleo S, Russello D. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: Influence of bilirubin and C-reactive protein. World J Gastroenterol 2012; 18(31): 4150-4155 [PMID: 22919247 DOI: 10.3748/wjg.v18.i31.4150] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i31/4150.htm |
| Number | Citing Articles |
| 1 |
Alessandra Fusco, Francesca Baorda, Lorenzo Porta, Alessandro A. Lemos, Lucio Caccamo, Eleonora Tobaldini, Giorgio Costantino. A woman with abdominal pain, jaundice and elevated CA 19.9. Internal and Emergency Medicine 2019; 14(4): 557 doi: 10.1007/s11739-018-1879-x
|
| 2 |
Giulia Malaguarnera, Saverio Latteri, Roberto Madeddu, Vito Emanuele Catania, Gaetano Bertino, Rosario Emanuele Perrotta, Francesco Dinotta, Michele Malaguarnera. High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer. Biomedicines 2020; 8(8): 265 doi: 10.3390/biomedicines8080265
|
| 3 |
Ding-Li Xu, Yi-Qun Wu, Chang Xin, Qi-Feng Zhou, Ming-Liang Chen, Huan-Jun Yan. Simple cholangitis induces extremely and recurrently elevated serum carbohydrate antigen 19-9 level. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 294 doi: 10.1016/j.hbpd.2019.03.008
|
| 4 |
G. C. Deng, Y. Lv, H. Yan, D. C. Sun, T. T. Qu, Y. T. Pan, Q. L. Han, G. H. Dai. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08943-w
|
| 5 |
Krishnakumar G. Kuttanchettiyar, Viswanathan Kollengode V, Meer M. Chisthi. Cyfra 21.1: A Useful Tumour Marker in Pancreatic Ductal Adenocarcinoma: Cross-Sectional Study. Cancer Control 2024; 31 doi: 10.1177/10732748241228037
|
| 6 |
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández, Stefan Holdenrieder, Huub van Rossum, Michel van den Heuvel. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology 2024; 46(s1): S35 doi: 10.3233/TUB-220023
|
| 7 |
Xue-Lei Li, Zhi-Peng Liu, Xing-Xing Su, Yi Gong, Yi-Shi Yang, Xiao-Lin Zhao, Zi-Mu Li, Jun-Jie Ding, Yi Zhu, Da-Long Yin, Chao Yu, Jin-Xue Zhou, Dong Zhang, Rui Ding, Wei Chen, Yao Cheng, Ping Yue, Zi-Ran Wang, Yan-Qi Zhang, Yan Jiang, Xian-Yu Yin, Jie Bai, Hai-Su Dai, Wan Yee Lau, Zhi-Yu Chen. Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study. International Journal of Surgery 2024; doi: 10.1097/JS9.0000000000001379
|
| 8 |
Xiang Wang, Li Liu, Zhi-Peng Liu, Jiao-Yang Wang, Hai-Su Dai, Xia Ou, Cheng-Cheng Zhang, Ting Yu, Xing-Chao Liu, Shu-Jie Pang, Hai-Ning Fan, Jie Bai, Yan Jiang, Yan-Qi Zhang, Zi-Ran Wang, Zhi-Yu Chen, Ai-Guo Li. Machine learning model to predict early recurrence in patients with perihilar cholangiocarcinoma planned treatment with curative resection: a multicenter study. Journal of Gastrointestinal Surgery 2024; 28(12): 2039 doi: 10.1016/j.gassur.2024.09.027
|
| 9 |
Qifan Yang, Lu Nie, Jian Xu, Hua Li, Xin Zhu, Mingwei Wei, Jun Yao. A machine learning-based predictive model for biliary stricture attributable to malignant tumors: a dual-center retrospective study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1406512
|
| 10 |
Xiaowen Gong, Yuerong Xuan, Chengshuai Pang, Chenyang Dong, Rui Cao, Zhigang Wei, Chaojie Liang. DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis. Clinica Chimica Acta 2024; : 120080 doi: 10.1016/j.cca.2024.120080
|
| 11 |
Sojun Hoshimoto, Shoichi Hishinuma, Hirofumi Shirakawa, Moriaki Tomikawa, Iwao Ozawa, Yoshiro Ogata. Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma. Oncology 2019; 96(6): 290 doi: 10.1159/000499050
|
| 12 |
Ross C. Smith. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 67 doi: 10.1007/978-3-642-40558-7_5
|
| 13 |
Rossella Indellicato, Aida Zulueta, Anna Caretti, Marco Trinchera. Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application. Cancers 2020; 12(6): 1509 doi: 10.3390/cancers12061509
|
| 14 |
Xumin Huang, Zipeng Lu, Kai Zhang, Guangfu Wang, Baobao Cai, Pengfei Wu, Jie Yin, Yi Miao, Kuirong Jiang. Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients). Pancreatology 2021; 21(6): 1092 doi: 10.1016/j.pan.2021.05.300
|
| 15 |
Richard J. Bold. RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy. Annals of Surgical Oncology 2013; 20(7): 2108 doi: 10.1245/s10434-012-2820-6
|
| 16 |
Tao Jiang, Shao-Cheng Lyu, Lin Zhou, Jing Wang, Han Li, Qiang He, Ren Lang. Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma. World Journal of Gastrointestinal Surgery 2021; 13(9): 1025-1038 doi: 10.4240/wjgs.v13.i9.1025
|
| 17 |
Lenka N. C. Boyd, Mahsoem Ali, Laura Kam, Jisce R. Puik, Stephanie M. Fraga Rodrigues, Eline S. Zwart, Freek Daams, Barbara M. Zonderhuis, Laura L. Meijer, Tessa Y. S. Le Large, Elisa Giovannetti, Hanneke W. M. van Laarhoven, Geert Kazemier. The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach. Cancers 2022; 14(2): 344 doi: 10.3390/cancers14020344
|
| 18 |
Kenta Anai, Yoshiko Hayashida, Issei Ueda, Eri Hozuki, Yuuta Yoshimatsu, Jun Tsukamoto, Toshihiko Hamamura, Norihiro Onari, Takatoshi Aoki, Yukunori Korogi. The effect of CT texture-based analysis using machine learning approaches on radiologists' performance in differentiating focal-type autoimmune pancreatitis and pancreatic duct carcinoma. Japanese Journal of Radiology 2022; 40(11): 1156 doi: 10.1007/s11604-022-01298-7
|
| 19 |
Hao Peng, Jixue Li, Xiaoru Zhou, Zhewen Nong, Ruiying Zhang, Pei Lu, Shasha Ye, Liping Lei, Chuang Qin, Jiangfa Li. A Composite Index for Distinguishing Benign and Malignant Obstructive Jaundice. International Journal of General Medicine 2024; : 5143 doi: 10.2147/IJGM.S485004
|
| 20 |
Bangbo Zhao, Qin Cheng, Hongtao Cao, Xingtong Zhou, Tianhao Li, Liangbo Dong, Weibin Wang. Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08204-w
|
| 21 |
Min Seong Kim, Tae Joo Jeon, Ji Young Park, Jeongmin Choi, Won Chang Shin, Seong Eun Park, Ji-Young Seo, Young Moon Kim. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease. The Korean Journal of Gastroenterology 2017; 70(2): 96 doi: 10.4166/kjg.2017.70.2.96
|
| 22 |
Amrita Sethi, Douglas A. Howell. Clinical Gastrointestinal Endoscopy. 2019; : 699 doi: 10.1016/B978-0-323-41509-5.00060-8
|
| 23 |
Giulia De Marchi, Salvatore Paiella, Claudio Luchini, Paola Capelli, Claudio Bassi, Luca Frulloni. Very high serum levels of CA 19‐9 in autoimmune pancreatitis: Report of four cases and brief review of literature. Journal of Digestive Diseases 2016; 17(10): 697 doi: 10.1111/1751-2980.12403
|
| 24 |
Neha Lad, David A. Kooby. Distal Cholangiocarcinoma. Surgical Oncology Clinics of North America 2014; 23(2): 265 doi: 10.1016/j.soc.2013.11.001
|
| 25 |
He Cheng, Guopei Luo, Kaizhou Jin, Zhiwen Xiao, Yunzhen Qian, Yitao Gong, Xianjun Yu, Chen Liu. Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult Metastases. World Journal of Surgery 2021; 45(7): 2185 doi: 10.1007/s00268-021-06047-x
|
| 26 |
Xiang Li, Na Lu, Peijun Hu, Yiwen Chen, Liying Liu, Xinyuan Liu, Chengxiang Guo, Wenbo Xiao, Ke Sun, Jingsong Li, Xueli Bai, Tingbo Liang. Computed tomography-based delta radiomics of tumor core_edge combination for systemic treatment response evaluation in pancreatic cancer. Journal of Pancreatology 2024; 7(3): 181 doi: 10.1097/JP9.0000000000000148
|
| 27 |
Qi Zhang, Mao Ye, Cheng Lin, Manyi Hu, Yangyang Wang, Yu Lou, Quanming Kong, Jungang Zhang, Junjian Li, Yuhua Zhang, Tianxing Yang, Xu Sun, Weiyun Yao, Yongfei Hua, Haifeng Huang, Minghui Xu, Xiaoguang Wang, Xin Yu, Weifeng Tao, Runtian Liu, Yuming Gao, Tian Wang, Jianing Wang, Xiaobao Wei, Jiangchao Wu, Zhengping Yu, Chengwu Zhang, Chaohui Yu, Xueli Bai, Tingbo Liang. Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study. Gut 2023; 72(5): 996 doi: 10.1136/gutjnl-2022-327496
|
| 28 |
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Naoya Yoshida, Hideo Baba. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment. Surgery Today 2017; 47(5): 636 doi: 10.1007/s00595-016-1464-8
|
| 29 |
Evelyn Waugh, Juan Glinka, Daniel Breadner, Rachel Liu, Ephraim Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro. Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2): 229 doi: 10.14701/ahbps.23-107
|
| 30 |
Jianchun Xiao, Li Wang, Tao Hong, Binglu Li, Wei Liu, Qiang Qu, Chaoji Zheng, Xiaodong He, Dan Zhao. The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/5829893
|
| 31 |
Ziyun Shen, Jun Zhang, Haoda Chen, Weishen Wang, Wei Xu, Xiongxiong Lu, Yiran Zhou, Shiwei Zhao, Zhiwei Xu, Xiaxing Deng, Jiancheng Wang, Yuanchi Weng, Baiyong Shen. Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.575316
|
| 32 |
Yizhen Zhang, Qingwei Jiang, Qiang Wang, Yunlu Feng, Dongsheng Wu, Tao Guo, Shengyu Zhang, Xi Chen, Yingyun Yang, Wen Shi, Xi Wu, Aiming Yang. Predicting Malignancy of Biliary Stricture with a Nomogram in Patients with a Non-Malignant Endoscopic Tissue Diagnosis: A Retrospective Study. Cancer Management and Research 2021; : 7735 doi: 10.2147/CMAR.S333333
|
| 33 |
Adrianne Tsen, Mary Barbara, Laura Rosenkranz. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology 2018; 18(8): 862 doi: 10.1016/j.pan.2018.09.004
|
| 34 |
Ziyuan Zhu, Kai Cheng, Zhang Yun, Xiang Zhang, Xiaoyu Hu, Jing Liu, Fuhao Wang, Zheng Fu, Jinbo Yue. [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(11): 3425 doi: 10.1007/s00259-023-06271-8
|
| 35 |
Fiona Hand, Kevin C. Conlon. Pancreatic cancer. Surgery (Oxford) 2019; 37(6): 319 doi: 10.1016/j.mpsur.2019.03.005
|
| 36 |
Robert Dorrell, Swati Pawa, Yi Zhou, Neeraj Lalwani, Rishi Pawa. The Diagnostic Dilemma of Malignant Biliary Strictures. Diagnostics 2020; 10(5): 337 doi: 10.3390/diagnostics10050337
|
| 37 |
Camila Lopes Vendrami, Joon Soo Shin, Nancy A. Hammond, Kunal Kothari, Pardeep K. Mittal, Frank H. Miller. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Abdominal Radiology 2020; 45(5): 1371 doi: 10.1007/s00261-019-02210-0
|
| 38 |
Ali Abdul Hussein S. AL-Janabi, Ekhlas F. Tawfeeq. Interfering Effect of Black Tea Consumption on Diagnosis of Pancreatic Cancer by CA 19-9. Journal of Gastrointestinal Cancer 2017; 48(2): 148 doi: 10.1007/s12029-016-9855-z
|
| 39 |
Xiao-Jie Wang, Jun-Li Ke, Jian-Xia Xu, Jia-Ping Zhou, Yuan-Fei Lu, Qiao-Mei Zhou, Dan Shi, Ri-Sheng Yu. Radiographic Features and Clinical Factor for Preoperative Prediction in the Bulging Duodenal Papilla With Malignancy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.627482
|
| 40 |
Marco Trinchera, Adele Aronica, Fabio Dall’Olio. Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers. Biology 2017; 6(1): 16 doi: 10.3390/biology6010016
|
| 41 |
Mohamed O. Khalifa, Ossama A. Ahmed, Mohamed H.A. Fouad, Mohamed Abo El-Kassem Abo Deif, Mohamed Awad Mansour. Value of serum CA 19-9 in obstructive jaundice. Egyptian Liver Journal 2016; 6(3): 54 doi: 10.1097/01.ELX.0000515715.11964.86
|
| 42 |
Freddy Pereira-Graterol, Francisco Salazar-Marcano, Yajaira Venales-Barrios. Síndrome de Mirizzi que simulaba una neoplasia biliar maligna. Revista Colombiana de Cirugía 2020; 35(3): 507 doi: 10.30944/20117582.730
|
| 43 |
Soo Young Jang, Jin Sil Kim, Seung Yon Baek, Hye Ah Lee, Jeong Kyong Lee. Proposed nomogram predicting neoplastic ampullary obstruction in patients with a suspected ampulla of Vater lesion on CT. Abdominal Radiology 2021; 46(7): 3128 doi: 10.1007/s00261-021-02975-3
|
| 44 |
Ming-ming Xu, Amrita Sethi. Diagnosing Biliary Malignancy. Gastrointestinal Endoscopy Clinics of North America 2015; 25(4): 677 doi: 10.1016/j.giec.2015.06.011
|
| 45 |
Yuji Shimizu, Teiichi Sugiura, Ryo Ashida, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Katsuhiko Uesaka. Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Levels in Patients with Pancreatic Cancer. Annals of Surgical Oncology 2023; 30(9): 5792 doi: 10.1245/s10434-023-13564-7
|
| 46 |
Saverio Latteri, Vito Catania, Giulia Malaguarnera, Andrea Peri, Gaetano Bertino, Giuseppe Frazzetto, Antonio Borzì, Antonio Biondi, Rosario Perrotta, Michele Malaguarnera. Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer. Biomedicines 2018; 6(1): 24 doi: 10.3390/biomedicines6010024
|
| 47 |
Yudith Meityana Hernandita, Tomy Lesmana, Alphania Rahniayu. Diagnostic Accuracy of Clinical Features, Laboratory Features, and Ultrasound Imaging Compared to Intraoperative Findings in Patients with Obstructive Jaundice. JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga 2023; 14(1): 21 doi: 10.20473/juxta.V14I12023.21-25
|
| 48 |
Thijs J. Schouten, Iris W. J. M. van Goor, Galina A. Dorland, Marc G. Besselink, Bert A. Bonsing, Koop Bosscha, Lodewijk A. A. Brosens, Olivier R. Busch, Geert A. Cirkel, Ronald M. van Dam, Sebastiaan Festen, Bas Groot Koerkamp, Erwin van der Harst, Ignace H. J. T. de Hingh, Martijn P. W. Intven, Geert Kazemier, Mike S. L. Liem, Krijn P. van Lienden, Maartje Los, Vincent E. de Meijer, Gijs A. Patijn, Jennifer M. J. Schreinemakers, Martijn W. J. Stommel, Geert Jan van Tienhoven, Robert C. Verdonk, Helena M. Verkooijen, Hjalmar C. van Santvoort, I. Quintus Molenaar, Lois A. Daamen. The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis. Annals of Surgical Oncology 2024; 31(8): 4956 doi: 10.1245/s10434-024-15070-w
|